In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

This content is currently on FREE ACCESS, enjoy another 15 days of free consultation

In these unprecedented times, the ESC is doing everything it can to support its community: FREE access to all ESC 365 content until 31 July: explore more than 125,000 educational resources.

From 1 August onwards, support our mission by becoming a member.

Gut microbiome and heart failure with reduced ejection fraction in patients with coronary artery disease

Session Poster Session 3

Speaker Emilia Sawicka

Event : Heart Failure 2019

  • Topic : heart failure
  • Sub-topic : Heart Failure with Reduced Ejection Fraction
  • Session type : Poster Session

Authors : E Sawicka (Bialystok,PL), M Paniczko (Bialystok,PL), M Lapinska (Bialystok,PL), M Szpakowicz (Bialystok,PL), Z Stachurska (Bialystok,PL), P Lopienski (Bialystok,PL), M Puchalski (Bialystok,PL), E Tarasiuk (Bialystok,PL), A Szpakowicz (Bialystok,PL), P Sowa (Bialystok,PL), M Niemira (Bialystok,PL), M Kwasiewski (Bialystok,PL), J Bychowski (Bialystok,PL), B Sobkowicz (Bialystok,PL), KA Kaminki (Bialystok,PL)

E Sawicka1 , M Paniczko2 , M Lapinska2 , M Szpakowicz2 , Z Stachurska2 , P Lopienski3 , M Puchalski3 , E Tarasiuk4 , A Szpakowicz1 , P Sowa2 , M Niemira5 , M Kwasiewski6 , J Bychowski7 , B Sobkowicz4 , KA Kaminki1 , 1Medical University of Bialystok, Department of Cardiology, Department of Population Medicine and Civilization Diseases Prevention - Bialystok - Poland , 2Medical University of Bialystok, Department of Population Medicine and Civilization Diseases Prevention - Bialystok - Poland , 3Medical University of Bialystok, Students’ Scientific Group of the Department of Cardiology - Bialystok - Poland , 4Medical University of Bialystok, Department of Cardiology - Bialystok - Poland , 5Medical University of Bialystok, Center for Clinical Research - Bialystok - Poland , 6Medical University of Bialystok, Centre for Bioinformatics and Data Analysis - Bialystok - Poland , 7Regional Hospital in Bialystok, Department of Cardiology and Internal Diseases with the Subunit of Invasive Cardiology - Bialystok - Poland ,


Background: Coronary artery disease (CAD) is one of the most common causes of hospitalization and death in Europe. It might leads to heart failure with reduced ejection fraction (HF-REF), which results in disability and decreases quality of life.  As a consequence, new factors, like gut microbiome, that may lead to CAD, and then HF-REF are widely investigated.

Purpose: To evaluate gut microbiota composition in CAD population. To compare the composition of the intestinal microbiome of CAD patients with HF-REF and those who have ejection fraction (EF) at least of 40%.

Methods: The study included stool microbiome of 89 CAD patients, aged 64.3±7.4 years (72 males) who were hospitalized 12-18 months prior recruitment due to an acute coronary syndrome (n=57) or percutaneous coronary intervention (n=32). All patients underwent detailed assessment of health status, including echocardiography with biplane ejection fraction (EF) assessment. Based on EF, HF-REF subgroup was distinguished (n=12).

Stool samples were collected in Stool Tubes with DNA stabilizer. DNA was isolated with the use of the PSP-Spin Stool-DNA kit. Further analyses were based on the V3-V4 region of the 16S rRNA gene (Next Generation Sequencing method).

Results: We identified 8 clusters of bacteria (Table). The analysis revealed that the gut microbiome consists mostly of Bacteroidetes, Firmicutes and Actinobacteria, with the largest abundance of reads for Bacteroidetes (Table). HF-REF group was characterized with almost half of the operational taxonomic units reads in Firmicutes than group without HF-REF (Table). There was no difference in Firmicutes/Bacteroidetes ratio between study groups (Figure).

Conclusions: HF-REF among CAD patients was associated with altered microbiome composition. The analyses in larger subpopulations and in control group is required.


Patients with HF-REF (n=12)

Patients without HF-REF (n=77)

All coronary artery disease patients (n=89)

P value


11349.5 IQR: 4698 - 18406.5

9161 IQR: 5891 - 15058

9161 IQR: 5881 - 16069



3210 IQR: 2327 - 5499.5

6040 IQR: 3484 - 9826

5815 IQR: 3334 - 9470



67.5 IQR: 25.5 - 447.5

223 IQR: 46 - 770

205 IQR: 46 - 679



0 IQR: 0 - 8

4 IQR: 0 - 16

2 IQR: 0 - 14



6 IQR: 2 - 14.5

3 IQR: 1 - 8

3 IQR: 1 - 9



0 IQR: 0 - 0

0 IQR: 0 - 0

0 IQR: 0 - 0



0 IQR: 0 - 0

0 IQR: 0 - 3

0 IQR: 0 - 2



0 IQR: 0 - 0

0 IQR: 0 - 0

0 IQR: 0 - 0



0 IQR: 0 - 48.5

1 IQR: 0 - 62

0 IQR: 0 - 62


Table. The distribution of operational taxonomic unit reads in study groups.

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are